Lawrence Elmer

3.4k total citations
35 papers, 1.8k citations indexed

About

Lawrence Elmer is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Lawrence Elmer has authored 35 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 14 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Lawrence Elmer's work include Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (17 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Lawrence Elmer is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (17 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Lawrence Elmer collaborates with scholars based in United States, Germany and India. Lawrence Elmer's co-authors include Kimon J. Angelides, Vann Bennett, Jonathan R. Davis, Yogambal Srinivasan, Alexander M. Goberman, Francis S. Collins, John Valdes, Danilo A. Tagle, Karley Y. Little and Lian Zhang and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Lawrence Elmer

35 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Elmer United States 20 838 767 751 240 165 35 1.8k
L. Lachenmayer Germany 23 945 1.1× 516 0.7× 487 0.6× 204 0.8× 147 0.9× 54 1.8k
Kosei Ojika Japan 23 588 0.7× 770 1.0× 236 0.3× 298 1.2× 172 1.0× 75 1.7k
Alexander A. Velumian Canada 19 1.4k 1.6× 1.0k 1.4× 185 0.2× 370 1.5× 297 1.8× 32 2.3k
Ariel R. Ase Canada 27 1.0k 1.2× 831 1.1× 226 0.3× 505 2.1× 148 0.9× 57 2.2k
Michela Tantucci Italy 24 824 1.0× 489 0.6× 413 0.5× 302 1.3× 222 1.3× 46 1.8k
Anton Terasmaa Estonia 20 1.1k 1.4× 1.1k 1.4× 179 0.2× 181 0.8× 133 0.8× 43 2.1k
J.A. Aguirre Spain 21 874 1.0× 581 0.8× 158 0.2× 196 0.8× 177 1.1× 74 1.4k
Johannes Krupp France 24 1.4k 1.7× 1.3k 1.6× 361 0.5× 344 1.4× 196 1.2× 46 2.0k
Anne Kästner France 25 489 0.6× 338 0.4× 421 0.6× 128 0.5× 258 1.6× 42 1.7k
B.B. Fredholm Sweden 22 1.2k 1.4× 1.1k 1.4× 206 0.3× 220 0.9× 233 1.4× 41 2.4k

Countries citing papers authored by Lawrence Elmer

Since Specialization
Citations

This map shows the geographic impact of Lawrence Elmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Elmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Elmer more than expected).

Fields of papers citing papers by Lawrence Elmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Elmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Elmer. The network helps show where Lawrence Elmer may publish in the future.

Co-authorship network of co-authors of Lawrence Elmer

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Elmer. A scholar is included among the top collaborators of Lawrence Elmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Elmer. Lawrence Elmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hauser, Robert A., Daniel Kremens, Lawrence Elmer, et al.. (2019). Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials. Journal of Parkinson s Disease. 9(3). 591–600. 14 indexed citations
3.
Elmer, Lawrence, Jorge L. Juncos, Carlos Singer, et al.. (2018). Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease. CNS Drugs. 32(4). 387–398. 47 indexed citations
4.
LeWitt, Peter A., Werner Poewe, Lawrence Elmer, et al.. (2016). The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease. Clinical Neuropharmacology. 39(2). 88–93. 3 indexed citations
5.
Timmermann, Lars, Mahnaz Asgharnejad, Babak Boroojerdi, et al.. (2015). Impact of 6-month earlier versus postponed initiation of rotigotine on long-term outcome:post hocanalysis of patients with early Parkinson’s disease with mild symptom severity. Expert Opinion on Pharmacotherapy. 16(10). 1423–1433. 6 indexed citations
6.
Nausieda, Paul A., Ann Hsu, Lawrence Elmer, et al.. (2015). Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson’s Disease: Experience in Clinical Trials. Journal of Parkinson s Disease. 5(4). 837–845. 19 indexed citations
7.
Elmer, Lawrence, Dee E. Silver, Ann Hsu, et al.. (2015). Comparison of efficacy from phase 3 clinical trials of IPX066, an extended-release carbidopa-levodopa formulation, in Parkinson’s disease (P1.191). Neurology. 84(14_supplement). 1 indexed citations
8.
Nicholas, Anthony P., Rupam Borgohain, Pedro Chaná, et al.. (2014). A Randomized Study of Rotigotine Dose Response on ‘Off’ Time in Advanced Parkinson's Disease. Journal of Parkinson s Disease. 4(3). 361–373. 36 indexed citations
9.
Elmer, Lawrence. (2013). Rasagiline adjunct therapy in patients with Parkinson's disease: Post hoc analyses of the PRESTO and LARGO trials. Parkinsonism & Related Disorders. 19(11). 930–936. 27 indexed citations
10.
Elmer, Lawrence, Erwin Surmann, Babak Boroojerdi, & Joseph Jankovic. (2012). Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study. Parkinsonism & Related Disorders. 18(5). 488–493. 36 indexed citations
11.
Lyons, Kelly E., Joseph H. Friedman, Neal Hermanowicz, et al.. (2010). Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects. Clinical Neuropharmacology. 33(1). 5–10. 31 indexed citations
12.
Simuni, Tanya, Kelly E. Lyons, Rajesh Pahwa, et al.. (2009). Treatment of Early Parkinson’s Disease. European Neurology. 61(4). 206–215. 9 indexed citations
13.
Elmer, Lawrence & John M. Bertoni. (2008). The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy. Expert Opinion on Pharmacotherapy. 9(16). 2759–2772. 33 indexed citations
14.
Elmer, Lawrence, Steven Schwid, Shirley Eberly, et al.. (2006). Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms. Journal of the Neurological Sciences. 248(1-2). 78–83. 32 indexed citations
15.
Goberman, Alexander M. & Lawrence Elmer. (2004). Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease. Journal of Communication Disorders. 38(3). 215–230. 93 indexed citations
16.
Elmer, Lawrence. (2004). Cognitive issues in Parkinson's disease. Neurologic Clinics. 22(3). S91–S106. 6 indexed citations
17.
Strong, Theresa V., Danilo A. Tagle, John Valdes, et al.. (1993). Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genetics. 5(3). 259–265. 310 indexed citations
18.
Valdes, John, Danilo A. Tagle, Lawrence Elmer, & Francis S. Collins. (1993). A simple non-radioactive method for diagnosis of Huntington's disease. Human Molecular Genetics. 2(6). 633–634. 22 indexed citations
19.
Black, J.A., B. Friedman, Stephen G. Waxman, Lawrence Elmer, & Kimon J. Angelides. (1989). Immuno-ultrastructural localization of sodium channels at nodes of Ranvier and perinodal astrocytes in rat optic nerve. Proceedings of the Royal Society of London. Series B, Biological sciences. 238(1290). 39–51. 56 indexed citations
20.
Srinivasan, Yogambal, Lawrence Elmer, Jonathan R. Davis, Vann Bennett, & Kimon J. Angelides. (1988). Ankyrin and spectrin associate with voltage-dependent sodium channels in brain. Nature. 333(6169). 177–180. 351 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Lachenmayer Breakdown of academic impact, for papers by Kosei Ojika Breakdown of academic impact, for papers by Alexander A. Velumian Breakdown of academic impact, for papers by Ariel R. Ase Breakdown of academic impact, for papers by Michela Tantucci Breakdown of academic impact, for papers by Anton Terasmaa Breakdown of academic impact, for papers by J.A. Aguirre Breakdown of academic impact, for papers by Johannes Krupp Breakdown of academic impact, for papers by Anne Kästner Breakdown of academic impact, for papers by B.B. Fredholm
Rankless by CCL
2026